Introduction
According to new legal regulations of Republic of Croatia, only three eggs are allowed to be fertilized in a single treatment cycle as well as freezing and preserving of leftover egg cells. Freezing the supernumerary embryos is not allowed therefore, embryo selection by extended culture system until the blastocyst stage is not possible. Considering that the quality assessment, based solely on morphology, of the oocyte is more difficult than of the embryo, especially in cases of spontaneous fertilization (IVF/ET), a need for assessment of the follicular fluid content has emerged as well as need for indirect quality assessment of the oocytes using biochemical parameters. Previous studies have shown endocrinological differences of serum and follicular fluid values in patients undergoing IVF/ET procedures by highly purified or recombinant gonadotropines [1] . It has been shown that endocrinological environment of the oocyte may influence its fertilization potential and embryo development potential [2] . Certain follicular fluid content reflects the oocyte stage of development and follicle maturity and may be a quality marker for oocytes and follicles [3, 4] .
Gonadotropine levels directly influence ovarian steroidogenesis. Known roles of luteinizing hormone (LH) occur in theca cells during androgen synthesis stimulation during intraovarian steroidogenesis. Additional roles include completion of meiotic division and oocyte maturation as well as roles in corpus luteum function regulation. LH influences follicular theca cells androgen production that is then under the influence of FSH aromatized to estrogen in granulosa cells. Androgens stimulate follicular development and enhance FSH effects regarding follicular differentiation. Increased follicular androgen values lead to follicular atresia [5] [6] [7] [8] . The role of LH during the ovarian gonadotropine stimulating cycles remains controversial as well as its use in treating patients without a good ovarian response to stimulation. Preventing premature LH surge during the ovarian stimulation is an integral part of classic and antagonistic treatment protocols. Several studies have shown that extreme LH suppression during ovarian stimulation negatively influences the treatment outcome [9] [10] [11] . Lower pregnancy success rate of antagonistic stimulation protocols is directly related to extremely low LH values in such patients, and debates regarding the low LH cutoff values remain. Several borderline serum values of LH have been suggested as "very low" < 3, <1.8, <1, <0.7 <0.5 IU/L [12] [13] [14] [15] [16] [17] . Recent studies include LH "window", range of values during ovulation stimulation that are optimal for success of IVF/ET treatment procedures [18] [19] [20] .
The aim of this pilot research was to determine the mean serum and follicular fluid LH and estradiol values in patients treated by IVF/ET (ICSI) after completed ovarian stimulation (at the day of oocyte aspiration), and to determine the range of values for these hormones with higher chances of conceiving pregnancies.
Material and Methods
The pilot study has included 31 normogonadotropic patients treated by IVF/ET (ICSI) procedures due to male infertility factors (n = 21, 67,7%) and women with tubal infertility factors (n = 10, 32,3%). Patients with idiopathic infertility, chronic anovulation, endometriosis and uterine malformations have been excluded. Age of the patients was between 20 -35 years. BMI was in the range from 18 to 28 kg/m 2 . The total of 8 patients have conceived (8/31 = 25,8%). Some patients have had a low response (less than 5 oocytes per started cycle) to gonadotropine stimulation (n = 10, 32,3%). All patients underwent stimulation in long agonistic protocol (Decapeptiyl 0.1mg -from 21.d. of the previous cycle, Menopur 150 -225 IU/day from 3.d. of the stimulated cycle, Ferring Germany). Folliculometry has been performed since the 8. d. of cycle, and hCG (Choragon 10 000 IU i.m., Ferring Germany) injection was administered after three follicles between 16 and 18mm in diameter have been confirmed by ultrasonography. Oocyte aspiration was guided by ultrasonography and performed 34-36 hours after hCG injection. Ultrasonographic measures were performed using vaginal probe attached to Aloca sector scanner (Model SSD 5500 Aloka Co., Ltd Japan). Embryo transfer was performed on the 3.d. since oocyte fertilization. All patients have vaginally received microinized progesterone (600mg/day) from the day of embryo transfer. Considering the age of the patients, 2 embryos at most have been transferred. Blood for assessment of LH and estradiol (E2) was collected immediately before oocyte aspiration. During the aspiration of each individual follicle, after the separating the oocyte and cumulus oophorus, a follicular fluid from three biggest follicles has been collected as separate samples. Collected samples of body fluids (serum n = 31, follicular fluid n = 93) were centrifuged and supernatant was separated, aliquoted, frozen and stored at -20°C. LH and E2 were measured in serum and follicular fluids. Tests were performed at the Department of nuclear medicine, using commercially available kits for sequentional competitive immunoassay method (Immulite/Immulite 1000 systems, DPC USA and Siemens, UK). Immunoassay sensitivity was 0.1mIU/ ml. Pregnancy was confirmed by measuring beta hCG and all pregnancies were clinically confirmed by vaginal ultrasonography after 21 days since the embryo transfer. Test results were analyzed using basic statistic methods, correlation and Fisher exact test.
Results
Mean serum LH value in healthy patients was 0.73 IU/L, which is a result of good "down regulation" by gonadotropin agonists in long treatment protocol. Mean serum E2 values was 2.90 nmol/L (Table 1) .
Follicular LH values were higher that serum values and were in the range of 1 -10.50 IU/L, with mean value of 3.13 IU/L. Range of follicular E2 was 709.70 -7340.0 nmol/L (Table 2) .
Student T test did not confirm statistically significant differences between LH and E2 values (serum and follicular fluids) in patients who got pregnant and those had low response to ovarian stimulation. Correlation of serum and follicular LH values was positive and determined as 0.41. Serum LH value of 0.5 IU/L (deep "down regulation" in literature) correlates with follicular value of approximately 3 IU/L. (Figure 1 the borderline value of 3 IU/L (corresponding to deep "down regulation") most of the results are below the defined value. If the cutoff LH value is higher than 3.1 IU/L, the ratio of the result related to pregnancy is 29.4% (10/34), and if the borderline value is lower than 3 IU/L, the ratio of the results related to pregnancy is 22.03%, (13/59), Table 3 . Correlation of follicular LH and E2 values is 0.19. (Figure 2 ). Cutoff value of E2 determined using follicular LH and follicular E2 correlation was 2100 nmol/L. If we separate the E2 values according to cutoff value (determined by correlation) most of them were found below the defined value. If the cutoff E2 value was lower than 2100 nmol/L the ratio of results related to pregnancy was 29,4% (15/51). If the follicular E2 values were higher than 2100 nmol/L the ratio of results related to pregnancy was ( 7,1%, 3/42). The observed differences were significant ( p 0.03). Values of follicular LH lower than 1.1 IU/L and follicular E2 lower than 1100 nmol/L were not related to pregnancy.
Discussion
Based on the preliminary results of this study, it is possible to predict a treatment outcome of IVF/ET (ICSI) procedure. Follicular LH values higher than 3.1 IU/L and follicular E2 values < than 2100 nmol/L indicate higher conceiving probability. Our results can be fit in previous findings on negative effects of low LH values in IVF treatment procedures [12, 18, 20] . Due to the size of the sample, a statistical significance between the results was not shown. It has been shown earlier that LH,GH and IL-1 have an effect on post fertilization oocyte development potential. Follicular LH reflects the effects of exogenous gonadotropins on follicle and positively correlates with post fertilization oocyte development and with rate of embryo hatching. LH content in gonadotropins is desired for optimizing the follicular development and oocyte maturation [21, 22] . Analyzed follicles in this research were chosen using ultrasonography examination and dimension determination greater than 16mm. Samples of three biggest follicles were analyzed regardless of the total number of follicles obtained by stimulation and that is different to findings of Smitz et al. [1] who have analyzed all follicles content obtained in stimulation. Advantage of our study was that the samples analyzed were those of follicular fluids of healthy patients on a day of oocyte aspiration so only the samples containing oocyte were chosen Mendoza et al. [2] had similar research of follicular fluid correlation with oocyte and embryo quality in both women who have and have not conceived. LH stimulates steroidogenesis in the follicle and positively influences on follicular E2 concentration proven by the positive correlation of these values in our study. However, our findings show tendency of conceiving at lower E2 values, unlike results of Mendoza [2] who had higher values in successful cycles. Recent studies have shown that the deep LH suppression in agonistic protocols combined with recombinant FSH stimulation may have a negative effect on IVF treatment outcome [9] . Ovarian stimulation in our pilot study was performed using highly purified urinary gonadotropines containing LH. LH serum values of 0.5 IU/L that is deep "down regulation" in literature, correlate to follicular values of 3 IU/L and that is higher than the values presented by Mendoza in her study [2] . Within the new legal framework, follicular fluid content analysis may contribute to oocyte quality assessment and selection of those oocytes with better fertilization potential. In that way, a higher success rate of treatments with small quantities of biological materials can be achieved. According to our results we believe that rapid assay of biochemical parameters (LH and E2) in follicular fluid may help to select oocyte with bether developmental potential after fertilisation in fresh cycle, or selection of good oocyte for other procedures likewise vitrification or slow freezing. Relations between oocyte quality (morphology, fertilisation and developmental potential) and biochemical parameters remains to be elucidated in further investigations. Follicular fluid hormone analysis may also help in cases of repeated treatment failures for modifying the treatment protocols of those patients. Fertilisation of only three oocyte is legal limitation for assisted reproduction in Republic of Croatia. There is no possibility to create more than three embryos in one fresh or secundary cycle. "Quick" evaluation of follicular fluid, in this moment, we consider as posibility to overcome this legal obstacle and to influence on the quality and results of assisted reproduction procedures.
Number of good quality oocytes is first important factor of cycle qualification and number of created embryos is second level that determines the succes of assisted reproduction. In this moment we have no scientific evidence to challenge legal restriction in Croatia.
